These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38942797)

  • 1. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells.
    Alashkar Alhamwe B; Ponath V; Alhamdan F; Dörsam B; Landwehr C; Linder M; Pauck K; Miethe S; Garn H; Finkernagel F; Brichkina A; Lauth M; Tiwari DK; Buchholz M; Bachurski D; Elmshäuser S; Nist A; Stiewe T; Pogge von Strandmann L; Szymański W; Beutgen V; Graumann J; Teply-Szymanski J; Keber C; Denkert C; Jacob R; Preußer C; Pogge von Strandmann E
    Cell Mol Immunol; 2024 Aug; 21(8):918-931. PubMed ID: 38942797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
    Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
    Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    Li X; Xu H; Yi J; Dong C; Zhang H; Wang Z; Miao L; Zhou W
    J Cell Mol Med; 2021 May; 25(10):4671-4683. PubMed ID: 33811437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis.
    Karamitopoulou E; Shoni M; Theoharides TC
    Int J Immunopathol Pharmacol; 2014; 27(2):213-20. PubMed ID: 25004833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
    Schuldner M; Dörsam B; Shatnyeva O; Reiners KS; Kubarenko A; Hansen HP; Finkernagel F; Roth K; Theurich S; Nist A; Stiewe T; Paschen A; Knittel G; Reinhardt HC; Müller R; Hallek M; von Strandmann EP
    Theranostics; 2019; 9(21):6047-6062. PubMed ID: 31534536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy.
    Yang D; Sun X; Moniruzzaman R; Wang H; Citu C; Zhao Z; Wistuba II; Wang H; Maitra A; Chen Y
    Gastroenterology; 2024 Jul; 167(2):298-314. PubMed ID: 38467382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?
    Eissmann MF; Buchert M; Ernst M
    Front Immunol; 2020; 11():1389. PubMed ID: 32719677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids.
    Buenafe AC; Dorrell C; Reddy AP; Klimek J; Marks DL
    Sci Rep; 2022 Mar; 12(1):3556. PubMed ID: 35241737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer.
    Yao H; Huang C; Zou J; Liang W; Zhao Y; Yang K; Zhong Z; Zhou S; Li J; Li Y; Xu L; Huang K; Lian G
    J Extracell Vesicles; 2024 Jul; 13(7):e12484. PubMed ID: 39041344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
    Ma Y; Hwang RF; Logsdon CD; Ullrich SE
    Cancer Res; 2013 Jul; 73(13):3927-37. PubMed ID: 23633481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness.
    Nigri J; Leca J; Tubiana SS; Finetti P; Guillaumond F; Martinez S; Lac S; Iovanna JL; Audebert S; Camoin L; Vasseur S; Bertucci F; Tomasini R
    Sci Signal; 2022 Aug; 15(745):eabg8191. PubMed ID: 35917363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway.
    Wang S; Gao Y
    Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells.
    Spear S; Candido JB; McDermott JR; Ghirelli C; Maniati E; Beers SA; Balkwill FR; Kocher HM; Capasso M
    Front Immunol; 2019; 10():542. PubMed ID: 30972056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.
    Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
    Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.